On January 12, 2025, the US FDA updated its recommendations regarding nitrosamine impurity acceptable intake limits, revising tables that outline acceptable levels for certain identified impurities in marketed products. Partner with Freyr to optimize your compliance strategies and ensure your products meet the new nitrosamine guidelines effectively.

Connect us: https://www.freyrsolutions.com/contact

Visit our Website: https://www.freyrsolutions.in/

#usfdaupdates #nitrsamineimpurity #compliancestrategies #pharmreg #freyrsolutions

Best Practices for Implementing an eCTD Submission Software | #ectd Submission Software

Explore how Freyr aided a US-based global pharmaceutical firm in the compilation, evaluation, and submission of an Annual Report (AR) to the US FDA. Download the case study now.

https://www.freyrsolutions.in/

#pharmareg #pharmaceuticals #regulatoryaffairs #usfda #amendment #casestudy #freyrsolutions